Reproductive Health
Payments companies reported to CMS as associated with Reproductive Health. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Reproductive Health, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Reproductive Health
These are the largest totals companies reported as associated with Reproductive Health. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Robert Green | Boston, MA | Neurology (Psychiatry & Neurology) | $5,296.00 |
| Pankaj Agrawal | North Miami Beach, FL | Neonatal-Perinatal Medicine | $3,535.00 |
| Ronald Wapner | New York, NY | Clinical Genetics (M.D.) | $3,375.00 |
| Kristen Wigby | San Diego, CA | Clinical Genetics (M.D.) | $3,040.50 |
| Robert Nussbaum | San Francisco, CA | Internal Medicine | $2,982.18 |
| Monica Wojcik | Boston, MA | Pediatrics | $2,562.00 |
| Michael Duyzend | Boston, MA | Clinical Genetics (M.D.) | $2,170.00 |
| David Keefe | New York, NY | Reproductive Endocrinology | $2,100.00 |
| Thomas Bourne | Little Rock, AR | Anatomic Pathology & Clinical Pathology | $2,000.00 |
| Kristen Suhrie | Indianapolis, IN | Neonatal-Perinatal Medicine | $1,616.00 |
Prescribed Reproductive Health?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.